Ms. Angelika Joos 


Angelika is responsible for Regulatory Policy issues within Merck Sharp & Dohme's Global Regulatory Affairs department since  2001 and heads the EU office in Brussels. Over the past 18 years, she has gained strategic as well as operational experience with all regulatory procedures and various products in different therapeutic areas.

In her current position as Executive Director, Global Regulatory Policy she is responsible for monitoring and implementing Regulatory Policies & Procedures and advising the company on Regulatory strategies. In this capacity she oversees activities in Europe, Middle East, Africa and Asia-Pacific and actively identifies opportunities that align with MSD's business priorities.

She has over 15 years experience of working with various trade associations and professional organsations. At EU level she represents MSD in various Committees of EFPIA and EuropaBio and Regulatory & Technical Policy Committee. She was member and later chair of the DIA Advisory Council Europe from 2008-2015 and has become a DIA Board member in 2014. Her main interests are related to clinical trials, HTA, paediatrics and patient involvement.